Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ZURA

Zura Bio (ZURA)

Zura Bio Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ZURA
DateTimeSourceHeadlineSymbolCompany
2:07PMiHub NewswireFeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
04/18/20249:22AMBusiness WireZura Bio Announces Oversubscribed $112.5 Million Private PlacementNASDAQ:ZURAZura Bio Ltd
04/08/20246:00AMBusiness WireZura Bio Announces Robert Lisicki as CEO and DirectorNASDAQ:ZURAZura Bio Ltd
03/28/20246:00AMBusiness WireZura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive OfficerNASDAQ:ZURAZura Bio Ltd
03/04/20246:00AMBusiness WireZura Bio Announces Participation at March ConferencesNASDAQ:ZURAZura Bio Ltd
02/23/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
02/14/20249:02AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZURAZura Bio Ltd
02/02/20246:00AMBusiness WireZura Bio Announces Participation at February Investor ConferencesNASDAQ:ZURAZura Bio Ltd
01/26/202411:32AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
01/26/202411:30AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
01/26/202411:27AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
01/11/20245:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
01/08/20246:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
01/08/20246:00AMBusiness WireZura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMONASDAQ:ZURAZura Bio Ltd
01/03/20246:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
01/03/20246:00AMBusiness WireZura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology SummitNASDAQ:ZURAZura Bio Ltd
12/04/20236:00AMBusiness WireZura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in BangkokNASDAQ:ZURAZura Bio Ltd
11/17/20235:53PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
11/14/20236:00AMBusiness WireZura Bio Appoints Arnout Ploos van Amstel to its Board of DirectorsNASDAQ:ZURAZura Bio Ltd
11/13/20236:30AMBusiness WireZura Bio Reports Third Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:ZURAZura Bio Ltd
10/25/20234:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
10/02/20239:54PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
10/02/20239:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
09/15/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZURAZura Bio Ltd
09/14/20235:01PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ZURAZura Bio Ltd
09/14/20234:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
09/12/20235:00AMBusiness WireZura Bio Enters into Sponsored Research Agreement with Benaroya Research InstituteNASDAQ:ZURAZura Bio Ltd
08/24/20239:54PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ZURAZura Bio Ltd
08/14/20237:00AMBusiness WireZura Bio Reports Second Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:ZURAZura Bio Ltd
08/11/20235:13PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ZURAZura Bio Ltd
 Showing the most relevant articles for your search:NASDAQ:ZURA